<i>Lactobacillus Reuteri</i> 6475 Prevents Bone Loss in a Clinically Relevant Oral Model of Glucocorticoid-Induced Osteoporosis in Male CD-1 Mice.

Although results did not reach statistical significance because of small sample size, this study laid the groundwork for future studies investigating LR 6475 as a clinically effective therapeutic option to prevent bone loss and demonstrates the translational promise of LR 6475 from preclinical models into the clinic.

also in 111,027 other papers